Quick Answer
Bluejay Diagnostics, Inc. reported Total Assets of $7.12 million for the year ending 2025.
- Bluejay Diagnostics, Inc. showed an increase of +6.9% in Total Assets from 2024 to 2025.
- This data is from Bluejay Diagnostics, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $3.62 million | Q1 2022: $20.08 million | Q2 2022: $18.07 million | Q3 2022: $15.71 million | Q1 2023: $10.89 million | Q2 2023: $8.48 million | Q3 2023: $8.25 million | Q1 2024: $5.08 million | Q2 2024: $10.86 million | Q3 2024: $8.35 million | Q1 2025: $5.28 million | Q2 2025: $6.40 million | Q3 2025: $4.89 million.
- Over the full 6 years of available data (2020 to 2025), Bluejay Diagnostics, Inc.'s Total Assets has grown by 369.2%.
- Historical annual values: Fiscal year 2025: $7.12 million | Fiscal year 2024: $6.66 million | Fiscal year 2023: $4.87 million | Fiscal year 2022: $13.52 million | Fiscal year 2021: $21.02 million | Fiscal year 2020: $1.52 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: